Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Suzhou Basecare Medical Corp. Ltd. Class H ( (HK:2170) ) has issued an announcement.
Suzhou Basecare Medical Corp. Ltd. has announced an upcoming board meeting scheduled for March 28, 2025. The meeting will focus on reviewing and approving the company’s annual results for the year ending December 31, 2024, and discussing the potential recommendation of a final dividend. This announcement indicates the company’s ongoing commitment to transparency and shareholder engagement, potentially impacting its market position and investor relations.
More about Suzhou Basecare Medical Corp. Ltd. Class H
Suzhou Basecare Medical Corp. Ltd. is a company based in the People’s Republic of China, operating in the medical industry. It focuses on providing medical products and services, with a particular emphasis on genetic testing and related healthcare solutions.
YTD Price Performance: 42.70%
Average Trading Volume: 139,437
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$1.01B
For an in-depth examination of 2170 stock, go to TipRanks’ Stock Analysis page.